← Search

Data · dataset · 2026

Development of biomaterial-based 3D printed drug-eluting scaffolds for bone cancer applications

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32826068.v1

Bone cancer remains a predominant site of metastatic progression and poses substantial therapeutic challenges, highlighting the need for customised drug delivery systems (DDSs), such as implantable devices, to address the limitations of conventional therapies and improve clinical outcomes.

Description

This study investigates the design and development of novel and multifunctional 3D printed scaffolds aimed at simultaneous pain management, segmental bone defect repair, and adjuvant treatment for bone metastases.

Initially, procaine (PRC) loaded biopolymeric scaffolds composed of poly(caprolactone) (PCL) and chitosan (CS) were developed for localised post-operative multimodal analgesia, achieving a sustained release. Subsequently, composite scaffolds consisted of PCL and the bioceramics hydroxyapatite (HA) or b-tricalcium phosphate (TCP) were engineered to systematically assess their physicochemical, mechanical characteristics and cytocompatibility, with the overarching objective of advancing bone-mimetic implant design.

Read the rest (2 more)

In the next step HA microparticles were functionalised with zoledronic acid (ZLD) and incorporated into PCL 3D printed scaffolds, establishing a localised, sustained release platform as potential adjuvant treatment for cytotoxic agents and osteoclast resorption inhibition. Finally, multi-material 3DP was employed for the fabrication of PCL-based multi-layer scaffolds, as multifunctional drug-loaded platforms, with adjusted geometrical features aiming to enhance vascularisation and tissue regeneration.

Overall, this thesis demonstrated that comprehensive optimisation of biomaterial formulations and processing parameters enabled the fabrication of reproducible, mechanically robust scaffolds with sustained drug release, advancing customised biomaterial-based DDSs as promising strategies for customised and multimodal bone cancer treatment.<br><br><i>Thesis is embargoed until 31 December 2030.</i>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 3 source records, 13 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3282606813 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3282606813 d agoJSON v1
DMU Figshareoai:figshare.com:article/3282606813 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:group:3214enrichment · zivahub uct ac zataxonomy-embedding@1.1.0title+keywords+description (71%)
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:medicine-healthmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title